After The Stock Fell -10.48% Over The Week, Is Niagen Bioscience Inc (NASDAQ: NAGE) Still A Buy?
Niagen Bioscience Inc (NASDAQ:NAGE)’s traded shares stood at 1.37 million during the last session, with the company’s beta value hitting 2.12. At the close of